NCT06430788: A Study of Emapalumab for Pediatric Aplastic Anemia |
|
|
| Recruiting | 2 | 55 | US | Emapalumab, Gamifant | Memorial Sloan Kettering Cancer Center | Aplastic Anemia, Cytopenia, Hypocellular Marrow | 05/29 | 05/29 | | |
BRIDGE, NCT05787574: A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition |
|
|
| Recruiting | 2 | 39 | US | Emapalumab, Fludarabine and Dexamethasone, Stem Cell Transplant | Memorial Sloan Kettering Cancer Center, Sobi, Inc. | Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases | 03/27 | 03/27 | | |
NCT02963064: JSP191 Antibody Targeting Conditioning in SCID Patients |
|
|
| Recruiting | 1/2 | 40 | US | Humanized anti-CD117 Monoclonal Antibody (JSP191) | Jasper Therapeutics, Inc. | SCID | 06/25 | 06/28 | | |
